The European financial advisory landscape for Healthcare Technology (HealthTech) and Medical Technology (MedTech) is undergoing a structural realignment, transitionally termed the Great Rationalisation. This shift represents a departure from the liquidity-fueled, growth-at-all-costs environment of the early 2020s toward a highly disciplined, metrics-centric climate. Enterprise valuation in this environment is no longer determined by raw revenue expansion; instead, it is dicta

European Boutiques and Mid-Market Specialists. To navigate this highly fragmented and clinically complex market, a distinct group of boutique investment banks has carved out highly defensible advisory positions. The following table profiles the leading specialist boutiques, tech-focused powerhouses, and mid-market global connectors active across the European HealthTech, MedTech and Healthcare AI sectors.